View Financial HealthSunset Capital Assets 配当と自社株買い配当金 基準チェック /06Sunset Capital Assets配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Feb 19Aphex BioCleanse Systems, Inc Suspends Director Scott SmithAphex BioCleanse Systems, Inc. announces it has come to the attention of the Board of Directors of Aphex BioCleanse Systems, Inc., that on February 10, 2022, Board Member Scott Smith filed a legal action in the U.S. District Court for Massachusetts against the Company and two of its Directors. The object of the lawsuit is not to benefit the Company's shareholders but to financially benefit Scott Smith individually, and the litigation potentially damages shareholder interests. This litigation also clearly violates the "Schoon Doctrine", (Schoon v. Smith, No. 554, 2006 Del. Feb. 12, 2008) Accordingly, the Chairman of the Aphex Board of Directors, Thomas Fitzgerald has determined, effective immediately, to suspend Scott Smith from any, and all duties as a Board Director, pending a complete investigation of this matter and allow a review by the other full Board members.お知らせ • Jun 12Sunset Capital Assets, Inc. (OTCPK:SNST) acquired Business of US BioSolutions LLC.Sunset Capital Assets, Inc. (OTCPK:SNST) acquired Business of US BioSolutions LLC on June 11, 2021. As a part of the transaction, Sunset Capital Assets also acquired a patented Open-Cell Foam technology. The acquired business includes the product line: BioFoam face shields (BioShield), Wipes (BioWipes), Mitts (BioMitt), and Sponges (BioSponge), and a Hand Sanitizer and Surface Cleaner (BioWash). Scott Smith, Inventor of BioFoam will join Sunset Capital Assets as Chief Sustainability Officer. Sunset Capital Assets, Inc. (OTCPK:SNST) completed the acquisition of Business of US BioSolutions LLC on June 11, 2021.お知らせ • Mar 04Aphex Biocleanse Systems Announces Significant Purchase Order for Proprietary Non-Toxic Disinfecting Wipe AlternativeAphex BioCleanse Systems, Inc. announced that the Company has received a significant initial purchase order ("PO") from eTECH Channel, which has been helping companies build successful sales channels since 2014, for its proprietary Hy-IQ® Water non-toxic disinfecting wipes. eTECH Channel intends to offer Aphex's disinfecting wipes, which were announced last week, to its extensive distribution channel under the name Hy-IQ® Hand Wipes (the "Wipes"). This initial PO is for 4,950 gallons of 10x concentration DermAphex® product and fills requests for several of eTECH Channel's major national retail clients. Hy-IQ® Hand Wipes conform to the FDA monograph for hand disinfecting products that will be available in retail and healthcare facilities through eTECH Channel shortly.お知らせ • Feb 24Aphex BioCleanse Systems Broadens Offerings to Include Non-Toxic Sanitizing WipesAphex BioCleanse Systems, Inc. announced that the company has broadened its product offerings to include non-toxic sanitizing wipes formulated with its proprietary Hy-IQ® Water technology. Third-party studies have proven Hy-IQ® Water is effective against human coronavirus, swine flu, E. coli, influenza, Candida auris, Candida albicans, MRSA, and several additional pathogens. Hy-IQ® Water achieves these results through physics rather than chemicals, so Aphex sanitizing products are both highly effective and non-toxic. The global disinfectant products market is expected to reach $30.11 billion by 2027 partly due to an increase in demand for sanitizers and disinfectants during the COVID-19 pandemic. This presents a large market opportunity for Aphex's sanitizing wipes, which are the only water-based and non-toxic option on the market. The company will soon be announcing partnerships with several large-scale distributors that would like to offer its sanitizing wipes to their channels and is open to additional opportunities.お知らせ • Dec 18Aphex Biocleanse Systems Signs European Supply and Private Label Agreement for Dermaphex and Sanaphex ProductsAphex BioCleanse Systems, Inc. announced that the company has signed a supply and private label agreement with Qurexx B.V. ("Qurexx"). As part of the agreement, and following required European registration processes, Qurexx holds the authority to purchase, market and sell Aphex's DermAphex Hand Sanitizer and SanAphex Hard Surface Sanitizer throughout the European Union, the United Kingdom, Switzerland and Eastern Europe. Qurexx will purchase the products directly from Aphex and is expected to place a significant purchase order in the near future following the required European product registration approvals. Through this agreement, Aphex will leverage Qurexx's key partnerships and distribution channels to increase accessibility of the Company's water-based sanitization products across Europe. As part of its European expansion, Aphex has also registered its DermAphex® Hand Sanitizer and SanAphex® Hard Surface Sanitizer in Germany. With this registration, the Company can now begin shipping and selling products in the country.お知らせ • Nov 13Aphex BioCleanse Systems Appoints Mark Washo as Senior Vice President of Sales and MarketingAphex BioCleanse Systems, Inc. announced that seasoned sports and business marketing executive Mark Washo has joined the Company as Senior Vice President of Sales and Marketing. Prior to joining Aphex, Washo held a number of respected senior marketing positions over the course of almost three decades. In his most recent role, he served as the Chief Business Officer of Marina Auto Stadium and the Rochester Rhinos where he managed the day to day operations of the stadium and professional USL soccer team.お知らせ • Oct 13Aphex BioCleanse Systems, Inc. Announces Management AppointmentsAphex BioCleanse Systems, Inc. announced that Kevin Harrington and Mark Timm have joined the Company as advisors. Harrington joins Aphex at a key moment in the Company's growth as sanitization products are in high demand due to the global COVID-19 pandemic. The hand sanitizer market alone, which includes Aphex's alcohol-free hand sanitizer DermAphex®, is expected to see a compound annual growth rate (CAGR) of almost 46% in 2020. Throughout his career, Harrington has worked behind the scenes of business ventures and produced more than $5 billion in global sales. He has assisted in the successful launch of more than 500 products, in making dozens of millionaires and has been responsible for the launch of more than 20 businesses that have each topped $100 million in revenue. He has also been involved with iconic brands and celebrities such as Jack Lalanne, Tony Little, George Foreman. and Kim Kardashian, among others.決済の安定と成長配当データの取得安定した配当: SNSTの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: SNSTの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Sunset Capital Assets 配当利回り対市場SNST 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (SNST)n/a市場下位25% (US)1.4%市場トップ25% (US)4.2%業界平均 (Household Products)3.1%アナリスト予想 (SNST) (最長3年)n/a注目すべき配当: SNSTは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: SNSTは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: SNSTの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: SNSTが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/24 08:34終値2026/05/19 00:00収益N/A年間収益N/Aデータソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sunset Capital Assets, Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Feb 19Aphex BioCleanse Systems, Inc Suspends Director Scott SmithAphex BioCleanse Systems, Inc. announces it has come to the attention of the Board of Directors of Aphex BioCleanse Systems, Inc., that on February 10, 2022, Board Member Scott Smith filed a legal action in the U.S. District Court for Massachusetts against the Company and two of its Directors. The object of the lawsuit is not to benefit the Company's shareholders but to financially benefit Scott Smith individually, and the litigation potentially damages shareholder interests. This litigation also clearly violates the "Schoon Doctrine", (Schoon v. Smith, No. 554, 2006 Del. Feb. 12, 2008) Accordingly, the Chairman of the Aphex Board of Directors, Thomas Fitzgerald has determined, effective immediately, to suspend Scott Smith from any, and all duties as a Board Director, pending a complete investigation of this matter and allow a review by the other full Board members.
お知らせ • Jun 12Sunset Capital Assets, Inc. (OTCPK:SNST) acquired Business of US BioSolutions LLC.Sunset Capital Assets, Inc. (OTCPK:SNST) acquired Business of US BioSolutions LLC on June 11, 2021. As a part of the transaction, Sunset Capital Assets also acquired a patented Open-Cell Foam technology. The acquired business includes the product line: BioFoam face shields (BioShield), Wipes (BioWipes), Mitts (BioMitt), and Sponges (BioSponge), and a Hand Sanitizer and Surface Cleaner (BioWash). Scott Smith, Inventor of BioFoam will join Sunset Capital Assets as Chief Sustainability Officer. Sunset Capital Assets, Inc. (OTCPK:SNST) completed the acquisition of Business of US BioSolutions LLC on June 11, 2021.
お知らせ • Mar 04Aphex Biocleanse Systems Announces Significant Purchase Order for Proprietary Non-Toxic Disinfecting Wipe AlternativeAphex BioCleanse Systems, Inc. announced that the Company has received a significant initial purchase order ("PO") from eTECH Channel, which has been helping companies build successful sales channels since 2014, for its proprietary Hy-IQ® Water non-toxic disinfecting wipes. eTECH Channel intends to offer Aphex's disinfecting wipes, which were announced last week, to its extensive distribution channel under the name Hy-IQ® Hand Wipes (the "Wipes"). This initial PO is for 4,950 gallons of 10x concentration DermAphex® product and fills requests for several of eTECH Channel's major national retail clients. Hy-IQ® Hand Wipes conform to the FDA monograph for hand disinfecting products that will be available in retail and healthcare facilities through eTECH Channel shortly.
お知らせ • Feb 24Aphex BioCleanse Systems Broadens Offerings to Include Non-Toxic Sanitizing WipesAphex BioCleanse Systems, Inc. announced that the company has broadened its product offerings to include non-toxic sanitizing wipes formulated with its proprietary Hy-IQ® Water technology. Third-party studies have proven Hy-IQ® Water is effective against human coronavirus, swine flu, E. coli, influenza, Candida auris, Candida albicans, MRSA, and several additional pathogens. Hy-IQ® Water achieves these results through physics rather than chemicals, so Aphex sanitizing products are both highly effective and non-toxic. The global disinfectant products market is expected to reach $30.11 billion by 2027 partly due to an increase in demand for sanitizers and disinfectants during the COVID-19 pandemic. This presents a large market opportunity for Aphex's sanitizing wipes, which are the only water-based and non-toxic option on the market. The company will soon be announcing partnerships with several large-scale distributors that would like to offer its sanitizing wipes to their channels and is open to additional opportunities.
お知らせ • Dec 18Aphex Biocleanse Systems Signs European Supply and Private Label Agreement for Dermaphex and Sanaphex ProductsAphex BioCleanse Systems, Inc. announced that the company has signed a supply and private label agreement with Qurexx B.V. ("Qurexx"). As part of the agreement, and following required European registration processes, Qurexx holds the authority to purchase, market and sell Aphex's DermAphex Hand Sanitizer and SanAphex Hard Surface Sanitizer throughout the European Union, the United Kingdom, Switzerland and Eastern Europe. Qurexx will purchase the products directly from Aphex and is expected to place a significant purchase order in the near future following the required European product registration approvals. Through this agreement, Aphex will leverage Qurexx's key partnerships and distribution channels to increase accessibility of the Company's water-based sanitization products across Europe. As part of its European expansion, Aphex has also registered its DermAphex® Hand Sanitizer and SanAphex® Hard Surface Sanitizer in Germany. With this registration, the Company can now begin shipping and selling products in the country.
お知らせ • Nov 13Aphex BioCleanse Systems Appoints Mark Washo as Senior Vice President of Sales and MarketingAphex BioCleanse Systems, Inc. announced that seasoned sports and business marketing executive Mark Washo has joined the Company as Senior Vice President of Sales and Marketing. Prior to joining Aphex, Washo held a number of respected senior marketing positions over the course of almost three decades. In his most recent role, he served as the Chief Business Officer of Marina Auto Stadium and the Rochester Rhinos where he managed the day to day operations of the stadium and professional USL soccer team.
お知らせ • Oct 13Aphex BioCleanse Systems, Inc. Announces Management AppointmentsAphex BioCleanse Systems, Inc. announced that Kevin Harrington and Mark Timm have joined the Company as advisors. Harrington joins Aphex at a key moment in the Company's growth as sanitization products are in high demand due to the global COVID-19 pandemic. The hand sanitizer market alone, which includes Aphex's alcohol-free hand sanitizer DermAphex®, is expected to see a compound annual growth rate (CAGR) of almost 46% in 2020. Throughout his career, Harrington has worked behind the scenes of business ventures and produced more than $5 billion in global sales. He has assisted in the successful launch of more than 500 products, in making dozens of millionaires and has been responsible for the launch of more than 20 businesses that have each topped $100 million in revenue. He has also been involved with iconic brands and celebrities such as Jack Lalanne, Tony Little, George Foreman. and Kim Kardashian, among others.